Select a medication above to begin.
Kyzatrex
testosterone undecanoate
Black Box Warnings .
Blood Pressure Increases
only indicated in male pts w/ hypogonadal conditions assoc. w/ structural or genetic etiologies; may cause incr. BP that may incr. risk of major adverse cardiovascular events, incl. non-fatal MI, non-fatal stroke, and cardiovascular death; greater risk in pts w/ cardiovascular risk factors or established CVD; consider baseline cardiovascular risks and control BP prior to tx start; monitor BP after tx start or dose incr, then periodically and treat new-onset HTN or exacerbations of pre-existing HTN; weigh tx benefits vs. risks in pts who develop cardiovascular risk factors or CVD while on tx
Adult Dosing .
Dosage forms: CAP: 100 mg, 150 mg, 200 mg
Special Note
- [formulation clarification]
- Info: not interchangeable w/ other PO testosterone undecanoate products; do not substitute on a mg to mg basis
primary hypogonadism, male
- [100 mg PO qam up to 400 mg PO bid]
- Start: 200 mg PO bid; Max: 800 mg/day; Info: adjust dose based on testosterone levels; divide dose bid if >100 mg/day; give w/ food
hypogonadotropic hypogonadism, male
- [100 mg PO qam up to 400 mg PO bid]
- Start: 200 mg PO bid; Max: 800 mg/day; Info: adjust dose based on testosterone levels; divide dose bid if >100 mg/day; give w/ food
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.